TY  - JOUR
AU  - Ocio, Enrique M.
AU  - Montes-Gaisan, Carmen
AU  - Bustamante, Gabriela
AU  - Garzon, Sebastian
AU  - Gonzalez, Esther
AU  - Perez, Ernesto
AU  - Sirvent, Maialen
AU  - Arguinano, Jose Maria
AU  - Gonzalez, Yolanda
AU  - Rios, Rafael
AU  - de Miguel, Dunia
AU  - Grande, Marta
AU  - Fernandez, Alonso
AU  - Naves, Andrea
AU  - Rosinol, Laura
PY  - 2022
DO  - 10.1016/j.clml.2021.10.001
SN  - 2152-2650
UR  - https://hdl.handle.net/10668/25106
T2  - Clinical lymphoma myeloma & leukemia
AB  - The characteristics of patients with RRMM in the real-world setting often differ from those enrolled in clinical trials, challenging therapeutic decisions in day-to-day practice. We retrospectively analyzed the sociodemographic and clinical...
LA  - en
PB  - Cig media group, lp
KW  - Multiple myeloma
KW  - Relapsed
KW  - refractory multiple myeloma
KW  - Treatment
KW  - Sociodemographic characteristics
KW  - Real word data
KW  - Randomized controlled-trials
KW  - Bortezomib
KW  - Dexamethasone
KW  - Lenalidomide
KW  - Efficacy
KW  - Therapy
KW  - Phase-2
KW  - Safety
KW  - Burden
TI  - Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study
TY  - research article
VL  - 22
ER  -